A model study estimating the potential impact of increased use of sodium channel blockers (SCBs) among patients with partial-onset seizures suggests significant reductions in costs, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Two cross-sectional studies of the decision-making process, insurance coverage and disease-modifying therapy (DMT) choices of patients with multiple sclerosis, provide glimpses of patients’ preferences.
Patients with secondary-progressive multiple sclerosis (SPMS) have to endure more than just declining physical and cognitive function.
Cost-effectiveness analysis should incorporate net health improvement and a dollar threshold for quality-adjusted life-years, according to some experts.
A team of investigators recommends that clinicians prepare to discuss long-term affordability and relative efficacy of biologic DMARDS with their patients with RA, as out-of-pocket costs are expected to reach a “catastrophic” phase of coverage.
Mathematical Model Suggests It Is Cost-Effective to Combine Bariatric Surgery and Hip Replacement in Morbidly Obese Individuals
An analysis of a theoretical cohort of patients using a mathematical model suggests that it is cost-effective for morbidly obese individuals to have bariatric surgery prior to total hip arthroplasty (THA), compared with having hip-replacement surgery alone.
How can the high cost of healthcare be spread among all stakeholders to produce the biggest patient-care bang for the buck?
In the year following a relapse, patients with multiple sclerosis remained less productive and their health deteriorated further compared with patients with multiple sclerosis whose disease had not relapsed, according to analyses presented at the 2015 annual meeting of the American Academy of Neurology.
Clinical and in-hospital process variables are associated with hospital length of stay (LOS) in acute ischemic stroke patients, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
The costs for inpatient care are significantly affected by the age and sex of patients with multiple sclerosis (MS) who experience disease relapse, according to data presented at the 2015 annual meeting of the American Academy of Neurology.